111 related articles for article (PubMed ID: 19399471)
1. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
Staub E; Groene J; Heinze M; Mennerich D; Roepcke S; Klaman I; Hinzmann B; Castanos-Velez E; Pilarsky C; Mann B; Brümmendorf T; Weber B; Buhr HJ; Rosenthal A
J Mol Med (Berl); 2009 Jun; 87(6):633-44. PubMed ID: 19399471
[TBL] [Abstract][Full Text] [Related]
2. A Novel Strategy to Identify Prognosis-Relevant Gene Sets in Cancers.
Pu J; Yu H; Guo Y
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627247
[TBL] [Abstract][Full Text] [Related]
3. Comparative microarray data analysis for the expression of genes in the pathway of glioma.
Katara P; Sharma N; Sharma S; Khatri I; Kaushik A; Kaushal L; Sharma V
Bioinformation; 2010 Jun; 5(1):31-4. PubMed ID: 21346876
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of cancer-related signaling pathways.
Kessler T; Hache H; Wierling C
Front Physiol; 2013; 4():124. PubMed ID: 23760067
[TBL] [Abstract][Full Text] [Related]
5. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
Smith JJ; Deane NG; Wu F; Merchant NB; Zhang B; Jiang A; Lu P; Johnson JC; Schmidt C; Bailey CE; Eschrich S; Kis C; Levy S; Washington MK; Heslin MJ; Coffey RJ; Yeatman TJ; Shyr Y; Beauchamp RD
Gastroenterology; 2010 Mar; 138(3):958-68. PubMed ID: 19914252
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
Jorissen RN; Gibbs P; Christie M; Prakash S; Lipton L; Desai J; Kerr D; Aaltonen LA; Arango D; Kruhøffer M; Orntoft TF; Andersen CL; Gruidl M; Kamath VP; Eschrich S; Yeatman TJ; Sieber OM
Clin Cancer Res; 2009 Dec; 15(24):7642-7651. PubMed ID: 19996206
[TBL] [Abstract][Full Text] [Related]
7. Complementary strand microRNAs mediate acquisition of metastatic potential in colonic adenocarcinoma.
Chen DT; Hernandez JM; Shibata D; McCarthy SM; Humphries LA; Clark W; Elahi A; Gruidl M; Coppola D; Yeatman T
J Gastrointest Surg; 2012 May; 16(5):905-12; discussion 912-3. PubMed ID: 22362069
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
9. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
10.
Chen MS; Lo YH; Chen X; Williams CS; Donnelly JM; Criss ZK; Patel S; Butkus JM; Dubrulle J; Finegold MJ; Shroyer NF
Mol Cancer Res; 2019 Mar; 17(3):697-708. PubMed ID: 30606770
[TBL] [Abstract][Full Text] [Related]
11. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
12. Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis.
Kikuchi A; Ishikawa T; Mogushi K; Ishiguro M; Iida S; Mizushima H; Uetake H; Tanaka H; Sugihara K
Int J Cancer; 2013 May; 132(10):2295-302. PubMed ID: 23065711
[TBL] [Abstract][Full Text] [Related]
13. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
[TBL] [Abstract][Full Text] [Related]
14. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics.
Hong Y; Downey T; Eu KW; Koh PK; Cheah PY
Clin Exp Metastasis; 2010 Feb; 27(2):83-90. PubMed ID: 20143136
[TBL] [Abstract][Full Text] [Related]
15. CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling.
Ma Y; Chen Y; Zhan L; Dong Q; Wang Y; Li X; He L; Zhang J
Cell Death Discov; 2024 May; 10(1):219. PubMed ID: 38710698
[TBL] [Abstract][Full Text] [Related]
16. WIPF1 promotes gastric cancer progression by regulating PI3K/Akt signaling in a myocardin-dependent manner.
Su F; Xiao R; Chen R; Yang T; Wang D; Xu X; Hou X; Guan Q; Feng M
iScience; 2023 Nov; 26(11):108273. PubMed ID: 38026208
[TBL] [Abstract][Full Text] [Related]
17. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications.
Tarin M; Babaie M; Eshghi H; Matin MM; Saljooghi AS
J Transl Med; 2023 Oct; 21(1):745. PubMed ID: 37864163
[TBL] [Abstract][Full Text] [Related]
18. Inferring spatial transcriptomics markers from whole slide images to characterize metastasis-related spatial heterogeneity of colorectal tumors: A pilot study.
Fatemi M; Feng E; Sharma C; Azher Z; Goel T; Ramwala O; Palisoul SM; Barney RE; Perreard L; Kolling FW; Salas LA; Christensen BC; Tsongalis GJ; Vaickus LJ; Levy JJ
J Pathol Inform; 2023; 14():100308. PubMed ID: 37114077
[TBL] [Abstract][Full Text] [Related]
19. Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer.
Cao S; Chen C; Gu D; Wang Z; Xu G
Front Pharmacol; 2022; 13():991881. PubMed ID: 36860211
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
